Aims: Cerium oxide nanoparticles (CeONPs) have been recently introduced into the medical field for their antioxidant properties. The ability of CeONPs alone or in combination with spironolactone (SP) to attenuate monocrotaline (MCT)-induced pulmonary hypertension and associated right ventricular hypertrophy was studied in rats. A special emphasis was given to endothelin-1 pathway.
View Article and Find Full Text PDF